Completed PHASE1 INTERVENTIONAL 3-arm NCT03590392

Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)

A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Chikungunya Virus (CHIKV) Vaccine ChAdOx1 Chik in Healthy Adult Volunteers

Sponsor: University of Oxford

Conditions Chikungunya Fever

Interventions ChAdOx1 Chik

Updated 9 times since 2018 Last updated: Oct 17, 2019 Started: Jul 31, 2018 Primary completion: Sep 30, 2019 Completion: Sep 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Chikungunya Fever, this trial is completed. The trial is conducted by University of Oxford and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Nov 2019 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Oct 2019 — Nov 2019 [monthly]

Active Not Recruiting PHASE1

▶ Show 4 earlier versions

Sep 2019 — Oct 2019 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
Nov 2018 — Sep 2019 [monthly]

Recruiting PHASE1
Sep 2018 — Nov 2018 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Aug 2018 — Sep 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Oxford

Data source: University of Oxford

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oxford, United Kingdom